Seth joined OrbiMed in 2020 and is an Analyst on the Public Equity team. Prior to joining OrbiMed, Seth served as a healthcare policy fellow in the United States Senate, focusing on legislation governing the FDA and the reimbursement of new drugs and diagnostics. Seth earned his M.D. from Harvard Medical School and his Ph.D. from Harvard University where he studied cancer biology, biochemistry, and genomics at the Dana-Farber Cancer Institute and the Broad Institute. He completed his graduate studies as part of the NIH-sponsored Medical Scientist Training Program. Seth received his A.B. degree summa cum laude from Harvard University in Human Developmental and Regenerative Biology. Outside of the office, Seth can be found on exceedingly long walks with his fiancée, listening to the Yankees on the radio, or enjoying time with family, including his precocious nephew.